Preventative effects of parotid gland massage for salivary gland dysfunction at high-dose radioiodine therapy in patients with differentiated thyroid cancer who had received total thyroidectomy

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CRIS

Registry ID

KCT0003276

Enrollment

100

Registered

2018-10-18

Start date

2013-10-22

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Procedure/Surgery, Behavioral : Control group (n=50) 1. Taking sialogogue every 30 minutes from 4 hours after radioiodine ingestion and continue for 7 days during daytime (Sleep should be started afte

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. > 18 year-old 2. Differentiated thyroid cancer patient who received total thyroidectomy and planned to receive 3.7-5.6 GBq of l-131 for postoperative thyroid ablation

Exclusion criteria

Exclusion criteria: 1. Previous radioiodine therapy 2. External radiation history of the head and neck area 3. Any previous symptoms of salivary gland dysfunction 4. History of salivary gland disease 5. Autoimmune diseases involving the salivary gland (example: Rheumatoid arthritis, Sjogren's disease, lymphoma, AIDS)

Design outcomes

Primary

Measure	Time frame
Salivary gland scan;Serum amylase (salivary type)	—

Secondary

Measure	Time frame
Questionnaire for salivary gland abnormal symptoms or dysfunction	—

Countries

Korea, Republic of

Contacts

Public ContactSeung Hyun Son

Kyungpook National University Hospital

sshjt7@gmail.com+82-53-420-5432

Outcome results